CHI Advisors LLC
- SEC CIK
- 0001791468
- Latest filing
- Nov 13, 2023
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 11, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 20
- +1 vs. Q3 2021
- Portfolio value
- $301.3M
- −$41.3M (−12.1%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CRVSCorvus Pharmaceuticals, Inc. | COM | 400,000 | $964.0K | 0.3% | +234,073+141.1% | Added | History |
| KROSKeros Therapeutics, Inc. | COM | 17,518 | $1.02M | 0.3% | +4,891+38.7% | Added | History |
| OVIDOvid Therapeutics Inc. | COM | 400,000 | $1.28M | 0.4% | +166,490+71.3% | Added | History |
| GTHXG1 Therapeutics, Inc. | COM | 230,000 | $2.35M | 0.8% | +180,000+360.0% | Added | History |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 1,876,389 | $3.71M | 1.2% | +448,908+31.4% | Added | – |
| DTILPrecision Biosciences Inc | COM | 606,629 | $4.49M | 1.5% | −40,100−6.2% | Reduced | History |
| KZRKezar Life Sciences, Inc. | COM | 272,250 | $4.55M | 1.5% | +197,250+263.0% | Added | History |
| INZYInozyme Pharma, Inc. | COM | 892,057 | $6.08M | 2.0% | −28,207−3.1% | Reduced | History |
| AKUSAkouos, Inc. | COM | 836,120 | $7.11M | 2.4% | −21,907−2.6% | Reduced | History |
| ORTXOrchard Therapeutics plc | ADS | 6,449,856 | $8.51M | 2.8% | +2,367,884+58.0% | Added | History |
| CMPXCompass Therapeutics, Inc. | COM | 3,023,692 | $9.59M | 3.2% | +3,023,692 | New | History |
| IMAImageneBio, Inc. | COM | 814,756 | $10.2M | 3.4% | +499,756+158.7% | Added | History |
| ONCROncorus, Inc. | COM | 2,106,903 | $11.1M | 3.7% | +350,924+20.0% | Added | History |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 1,055,882 | $12.0M | 4.0% | 00.0% | Unchanged | History |
| Vectivbio Hldg AGH9060V101 | ORD SHS | 2,675,408 | $13.1M | 4.4% | +82,806+3.2% | Added | – |
| LRMRLarimar Therapeutics, Inc. | COM | 1,515,148 | $16.3M | 5.4% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,569,479 | $34.7M | 11.5% | +84,755+3.4% | Added | History |
| CGEMCullinan Therapeutics, Inc. | COM | 2,476,720 | $38.2M | 12.7% | +231,879+10.3% | Added | History |
| RPTXRepare Therapeutics Inc. | COM | 2,212,256 | $46.7M | 15.5% | −20,527−0.9% | Reduced | History |
| RXDXPrometheus Biosciences, Inc. | COM | 1,752,243 | $69.3M | 23.0% | −1,109,816−38.8% | Reduced | History |